RANIFIN is a H2 receptor antagonist, used as the hydrochloride salt to inhibitgastric acid secretion in the treatment of gastric and duodenal ulcer, gastroesophageal reflux disease, and conditions that cause gastric hypersecretion.
Stress ulceration of upper gastrointestinal tract
Adult: 50 mg by slow IV inj as priming dose followed by 0.125-0.25 mg/kg/hr as continuous IV infusion then transfer to oral dose of 150 mg bid once oral feeding is resumed. Child: 1 mg/kg (max: 50 mg) as slow IV inj over at least 2 min 6-8 hrly or 0.125-0.25 mg/kg/hr as continuous infusion.
Adult: Initially, 1 mg/kg/hr, may increase by increments of 0.5 mg/kg/hr beginning after 4 hr if necessary.
RANIFIN injection 50 mg/2ml
Each ml contains : Ranitidine 25 mg
Box, 5 ampoules @ 2 ml